GolimumabPersistent erythema multiforme: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1721卷 / 1期

关键词：

D O I：

10.1007/s40278-018-52174-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：137 / 137

相关论文

共 50 条

[21] Tofacitinib for Erythema Multiforme: A Case Report
Zhou, Yingying
Li, Tianhao
Xie, Hongyan
Xu, Tongtong
Yao, Yabo
Li, Chunxiao
DERMATITIS, 2022, 33 (02) : E13 - E14
[22] SalbutamolOral erythema multiforme: case report
Reactions Weekly, 2022, 1932 (1) : 530 - 530
[23] TozinameranBullous erythema multiforme: case report
Reactions Weekly, 2022, 1889 (1) : 296 - 296
[24] TozinameranAtypical erythema multiforme: case report
Reactions Weekly, 2023, 1958 (1) : 480 - 480
[25] DiphencyproneBullous erythema multiforme: case report
Reactions Weekly, 1998, 703 (1) : 7 - 7
[26] AdalimumabFirst report of erythema multiforme: case report
Reactions Weekly, 2004, 1010 (1) : 6 - 6
[27] GatifloxacinFirst report of erythema multiforme: case report
Reactions Weekly, 2003, 979 (1) : 12 - 13
[28] MoxifloxacinOral erythema multiforme: case report
Reactions Weekly, 2021, 1875 (1) : 222 - 222
[29] VancomycinBullous erythema multiforme: case report
Reactions Weekly, 2021, 1884 (1) : 427 - 427
[30] AcarboseGeneralised erythema multiforme: case report
Reactions Weekly, 1999, 763 (1) : 6 - 6

← 1 2 3 4 5 →